Based at our scientific campus, you will be required to have a Counter Terrorism Check security vetting check as a minimum. For meaningful National Security Vetting checks to be carried out individuals need to have lived in the UK for a sufficient period of time. You should normally have been resident in the United Kingdom for the last 3 years as the role requires Counter Terrorism Check (CTC) clearance. In exceptional circumstances UK residency less than the outlined periods may not necessarily bar you from gaining national security vetting and applicants should contact the Vacancy Holder/Recruiting Manager listed in the advert for further advice.
About the job
Job summary
The Countermeasures Development and Evaluation Centre is based at Porton and has approximately 250 staff, performing a range of research activities, including high containment level work. The department’s work covers a broad range of projects involving vaccine and therapeutic, discovery, evaluation, development, and research.
The Antimicrobial Development, Discovery and Diagnostics (AD3) team sits in the Countermeasures Development, Evaluation and Preparedness Division in the Public Health Microbiology Directorate within the Chief Scientific Officer Group. Its work focuses on the discovery, development and evaluation of antimicrobial therapies directed at UKHSA priority pathogens, with a particular focus on AMR/emerging pathogens.
The post holder will provide specialist laboratory skills in support of the bacteriophage ‘integrated pathway’ programme, which is developing a phage service to support clinical use of phage in the UK (including an in-house phage library). The post holder will also contribute towards developing novel phage susceptibility testing methods and supporting UK-based phage manufacture.